Uzbekistan's Pharma Sector Teams Up With Turkmen Partners For Joint Ventures
During the meeting, the parties discussed ongoing projects in the pharmaceutical sector, the implementation of international quality standards (GMP, GDP, GPP), and the development of biotechnology. They also explored prospects for joint production of syringes, dietary supplements, and children's nutrition products.
The meeting concluded with an agreement to maintain regular collaboration and conduct ongoing consultations between the partners.
Meanwhile, Uzbekistan's trade turnover with Turkmenistan reached $586.6 million from January through July 2025. This represents a decrease of approximately 22.5 percent compared to the same period in 2024 ($757.0 million), but an increase of about 19.1 percent compared to 2023 ($492.4 million).

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Nutritional Bar Market Size To Expand At A CAGR Of 3.5% During 2025-2033
- North America Perms And Relaxants Market Size, Share And Growth Report 2025-2033
- Primexbt Wins Global Forex Award For Best Multi-Asset Trading Platform
- Smart Indoor Gardens Market Growth: Size, Trends, And Forecast 20252033
- Excellion Finance Scales Market-Neutral Defi Strategies With Fordefi's MPC Wallet
- Japan Green Hydrogen Market Size To Reach USD 734 Million By 2033 CAGR Of 27.00%
Comments
No comment